Search Results

You are looking at 71 - 80 of 808 items for :

  • hormone therapy x
Clear All
Tristan Avril Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France

Search for other papers by Tristan Avril in
Google Scholar
PubMed
Close
,
Quentin Hennocq Datascience platform, Imagine Institute, Université Paris Cité, Paris, France

Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Close
,
Anne-Sophie Lambert Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France

Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Close
,
Juliane Leger Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France

Search for other papers by Juliane Leger in
Google Scholar
PubMed
Close
,
Dominique Simon Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France

Search for other papers by Dominique Simon in
Google Scholar
PubMed
Close
,
Laetitia Martinerie Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France

Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Close
, and
Claire Bouvattier Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France

Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
Close

cryptorchidism ( 1 ). It can be isolated or part of a combined pituitary hormone deficiency (CPHD) ( 2 ) and is usually in relation to a dysfunction in gonadotropin-releasing hormone (GnRH) secretion or action. The major clinical consequences of CHH are pubertal

Open access
Nikolina Zdraveska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Nikolina Zdraveska in
Google Scholar
PubMed
Close
,
Maja Zdravkovska Institute of Patophysiology and Nuclear Medicine, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Maja Zdravkovska in
Google Scholar
PubMed
Close
,
Violeta Anastasovska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Violeta Anastasovska in
Google Scholar
PubMed
Close
,
Elena Sukarova-Angelovska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Elena Sukarova-Angelovska in
Google Scholar
PubMed
Close
, and
Mirjana Kocova University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Mirjana Kocova in
Google Scholar
PubMed
Close

Introduction Thyroid hormones play important role in the processes of neuronal migration and differentiation, myelination and synaptogenesis and are essential for proper neurodevelopment ( 1 ). Congenital hypothyroidism (CH) is generally

Open access
Elin Kahlert Clinic of Gastroenterology and Endocrinology, University Medical Center Goettingen, Goettingen, Germany

Search for other papers by Elin Kahlert in
Google Scholar
PubMed
Close
,
Martina Blaschke Clinic of Gastroenterology and Endocrinology, University Medical Center Goettingen, Goettingen, Germany
Endokrinologikum Goettingen, Goettingen, Germany

Search for other papers by Martina Blaschke in
Google Scholar
PubMed
Close
,
Knut Brockmann Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, University Medical Center Goettingen, Goettingen, Germany

Search for other papers by Knut Brockmann in
Google Scholar
PubMed
Close
,
Clemens Freiberg Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, University Medical Center Goettingen, Goettingen, Germany

Search for other papers by Clemens Freiberg in
Google Scholar
PubMed
Close
,
Onno E Janssen Endokrinologikum Hamburg, Hamburg, Germany

Search for other papers by Onno E Janssen in
Google Scholar
PubMed
Close
,
Nikolaus Stahnke Endokrinologikum Hamburg, Hamburg, Germany

Search for other papers by Nikolaus Stahnke in
Google Scholar
PubMed
Close
,
Domenika Strik Endokrinologikum Berlin, Berlin, Germany

Search for other papers by Domenika Strik in
Google Scholar
PubMed
Close
,
Martin Merkel Endokrinologikum Hannover, Hannover, Germany

Search for other papers by Martin Merkel in
Google Scholar
PubMed
Close
,
Alexander Mann Endokrinologikum Frankfurt, Frankfurt/Main, Germany

Search for other papers by Alexander Mann in
Google Scholar
PubMed
Close
,
Klaus-Peter Liesenkötter Endokrinologikum Berlin, Berlin, Germany

Search for other papers by Klaus-Peter Liesenkötter in
Google Scholar
PubMed
Close
, and
Heide Siggelkow Clinic of Gastroenterology and Endocrinology, University Medical Center Goettingen, Goettingen, Germany
Endokrinologikum Goettingen, Goettingen, Germany

Search for other papers by Heide Siggelkow in
Google Scholar
PubMed
Close

estrogen replacement therapy to treat ovarian insufficiency and induce puberty. Although human growth hormone therapy (hGHT) has been established in TS patients, its efficacy varies and depends on many factors, including dose, duration, and age at treatment

Open access
Isabel M Abreu Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, Porto, Portugal

Search for other papers by Isabel M Abreu in
Google Scholar
PubMed
Close
,
Eva Lau Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

Search for other papers by Eva Lau in
Google Scholar
PubMed
Close
,
Bernardo de Sousa Pinto Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, Porto, Portugal

Search for other papers by Bernardo de Sousa Pinto in
Google Scholar
PubMed
Close
, and
Davide Carvalho Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Close

Introduction Subclinical hypothyroidism (SCH) is diagnosed biochemically when both serum-free thyroxine (FT4) and free triiodothyronine (FT3) are within the normal range, whereas the serum thyroid-stimulating hormone (TSH) is elevated ( 1

Open access
Mirjana Doknic Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Mirjana Doknic in
Google Scholar
PubMed
Close
,
Marko Stojanovic Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Close
,
Ivan Soldatovic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Institute of Medical Statistics and Informatics, Belgrade, Serbia

Search for other papers by Ivan Soldatovic in
Google Scholar
PubMed
Close
,
Tatjana Milenkovic Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia

Search for other papers by Tatjana Milenkovic in
Google Scholar
PubMed
Close
,
Vera Zdravkovic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
University Children’s Clinic, Belgrade, Serbia

Search for other papers by Vera Zdravkovic in
Google Scholar
PubMed
Close
,
Maja Jesic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
University Children’s Clinic, Belgrade, Serbia

Search for other papers by Maja Jesic in
Google Scholar
PubMed
Close
,
Sladjana Todorovic Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia

Search for other papers by Sladjana Todorovic in
Google Scholar
PubMed
Close
,
Katarina Mitrovic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia

Search for other papers by Katarina Mitrovic in
Google Scholar
PubMed
Close
,
Rade Vukovic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia

Search for other papers by Rade Vukovic in
Google Scholar
PubMed
Close
,
Dragana Miljic Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Dragana Miljic in
Google Scholar
PubMed
Close
,
Dragan Savic Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia

Search for other papers by Dragan Savic in
Google Scholar
PubMed
Close
,
Mihajlo Milicevic Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia

Search for other papers by Mihajlo Milicevic in
Google Scholar
PubMed
Close
,
Aleksandar Stanimirovic Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia

Search for other papers by Aleksandar Stanimirovic in
Google Scholar
PubMed
Close
,
Vojislav Bogosavljevic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia

Search for other papers by Vojislav Bogosavljevic in
Google Scholar
PubMed
Close
,
Sandra Pekic Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Sandra Pekic in
Google Scholar
PubMed
Close
,
Emilija Manojlovic-Gacic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Emilija Manojlovic-Gacic in
Google Scholar
PubMed
Close
,
Aleksandar Djukic Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

Search for other papers by Aleksandar Djukic in
Google Scholar
PubMed
Close
,
Danica Grujicic Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia

Search for other papers by Danica Grujicic in
Google Scholar
PubMed
Close
, and
Milan Petakov Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for other papers by Milan Petakov in
Google Scholar
PubMed
Close

of isolated GHD or multiple pituitary hormone deficiency (MPHD) during childhood. Stimulated peak GH of less than 15 mU/L was considered confirmatory for GHD in both tests ( 9 , 10 , 11 ). Prior to retesting, rhGH therapy was discontinued for at

Open access
Alexander A L Jorge Unidade de Endocrinologia-Genetica, LIM/25, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, Brazil

Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Close
,
Thomas Edouard Endocrine, Bone Diseases, and Genetics Unit, Children’s Hospital, Toulouse University Hospital, RESTORE INSERM UMR1301, Toulouse, France

Search for other papers by Thomas Edouard in
Google Scholar
PubMed
Close
,
Mohamad Maghnie Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genova, Italy
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy

Search for other papers by Mohamad Maghnie in
Google Scholar
PubMed
Close
,
Alberto Pietropoli Novo Nordisk Health Care AG, Global Medical Affairs Biopharm, Zürich, Switzerland

Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed
Close
,
Nicky Kelepouris Novo Nordisk Inc., Clinical, Medical and Regulatory Biopharm-RED, Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Close
,
Alicia Romano Department of Pediatrics, New York Medical College, Valhalla, New York, USA

Search for other papers by Alicia Romano in
Google Scholar
PubMed
Close
,
Martin Zenker Institute of Human Genetics & Department of Pediatrics, University Hospital, Otto-von-Guericke University Magdeburg, Magdeburg, Germany

Search for other papers by Martin Zenker in
Google Scholar
PubMed
Close
, and
Reiko Horikawa Department of Endocrine and Metabolism, National Center for Child Health and Development, Tokyo, Japan

Search for other papers by Reiko Horikawa in
Google Scholar
PubMed
Close

hormone therapy; IOS, International Outcome Study; NS, Noonan syndrome. In brief, the ANSWER program® was an observational, multicenter study conducted across 207 USA centers between 2002 and 2016, which monitored the long-term effectiveness and

Open access
Mojca Jensterle Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Mojca Jensterle in
Google Scholar
PubMed
Close
,
Nika Aleksandra Kravos Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Nika Aleksandra Kravos in
Google Scholar
PubMed
Close
,
Simona Ferjan Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Simona Ferjan in
Google Scholar
PubMed
Close
,
Katja Goricar University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, Ljubljana, Slovenia

Search for other papers by Katja Goricar in
Google Scholar
PubMed
Close
,
Vita Dolzan University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, Ljubljana, Slovenia

Search for other papers by Vita Dolzan in
Google Scholar
PubMed
Close
, and
Andrej Janez Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Andrej Janez in
Google Scholar
PubMed
Close

-up included 6085 time-points with a subset of anthropometric, reproductive, hormonal and metabolic parameters. Table 1 Baseline characteristic and longitudinal follow-up to 7th year of therapy with metformin of clinical parameters in women with PCOS

Open access
Kaisu Luiro Department of Obstetrics and Gynecology, Reproductive Medicine Unit, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Search for other papers by Kaisu Luiro in
Google Scholar
PubMed
Close
,
Kristiina Aittomäki Department of Medical Genetics, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Kristiina Aittomäki in
Google Scholar
PubMed
Close
,
Pekka Jousilahti Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland

Search for other papers by Pekka Jousilahti in
Google Scholar
PubMed
Close
, and
Juha S Tapanainen Department of Obstetrics and Gynecology, Reproductive Medicine Unit, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Medical Research Center, PEDEGO Research Unit, Oulu, Finland

Search for other papers by Juha S Tapanainen in
Google Scholar
PubMed
Close

receptor mutation was discovered 20 years ago, but its long-term effects on health and morbidity, and the effect of estrogen hormone therapy (HT) have not been thoroughly investigated. There is evidence that some of the adverse events related to POI may be

Open access
Marie Oertel Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Marie Oertel in
Google Scholar
PubMed
Close
,
Christian G Ziegler Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

Search for other papers by Christian G Ziegler in
Google Scholar
PubMed
Close
,
Michael Kohlhaas Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Michael Kohlhaas in
Google Scholar
PubMed
Close
,
Alexander Nickel Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Alexander Nickel in
Google Scholar
PubMed
Close
,
Simon Kloock Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Simon Kloock in
Google Scholar
PubMed
Close
,
Christoph Maack Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Christoph Maack in
Google Scholar
PubMed
Close
,
Vasco Sequeira Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Vasco Sequeira in
Google Scholar
PubMed
Close
,
Martin Fassnacht Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Close
, and
Ulrich Dischinger Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Ulrich Dischinger in
Google Scholar
PubMed
Close

increasing knowledge of the gut–brain axis and the involved peptide hormones, the development of polyagonists therapies is only at its beginning and a co-administration of PYY3-36 and leptin ( 55 ) or PYY3-36 and amylin ( 56 ) may be further promising

Open access
Ayse Nurcan Cebeci Paediatric Endocrinology, Department of Friedrich-Alexander University Hospital, Erlangen, Germany

Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Close
,
Vera Schempp Paediatric Endocrinology, University Hospital, Bonn, Germany

Search for other papers by Vera Schempp in
Google Scholar
PubMed
Close
,
Katharina Förtsch Paediatric Endocrinology, University Hospital, Düsseldorf, Germany

Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Close
,
Bettina Gohlke Paediatric Endocrinology, University Hospital, Bonn, Germany

Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Close
,
Michaela Marx Paediatric Endocrinology, Department of Friedrich-Alexander University Hospital, Erlangen, Germany

Search for other papers by Michaela Marx in
Google Scholar
PubMed
Close
,
Helmuth-Guenther Dörr Paediatric Endocrinology, Department of Friedrich-Alexander University Hospital, Erlangen, Germany

Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Close
, and
Joachim Woelfle Paediatric Endocrinology, Department of Friedrich-Alexander University Hospital, Erlangen, Germany

Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
Close

, and outcomes were analysed. GD is defined as (i) elevated free thyroxine (fT4) (normal range (NR): 10–25 pmol/L), (ii) completely suppressed thyroid-stimulating hormone (TSH) (NR: 0.5–4.5 mU/L), and (iii) elevated thyrotrophin receptor antibodies

Open access